Peter Lansdorp, MD, PhD
Co-Founder and Chief Scientific Officer
Peter Lansdorp and his research team at the Terry Fox laboratory of the BC Cancer Agency developed and perfected the Flow FISH procedure at a time when his research was mainly focused on telomere biology. This knowledge and technology were successfully translated to licensed and validated clinical testing service with RepeatDx in 2008. Peter is a Distinguished Scientist at the BC Cancer Agency and a Professor in Medical Genetics at the University of British Columbia. He studied medicine at Erasmus University Rotterdam and gained his PhD at the University of Amsterdam, The Netherlands. His current research work focuses on genome analysis and the role of genetic instability in ageing and cancer.